Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Andreas, M; Burri, H; Praz, F; Soliman, O; Badano, L; Barreiro, M; Cavalcante, JL; de Potter, T; Doenst, T; Friedrichs, K; Hausleiter, J; Karam, N; Kodali, S; Latib, A; Marijon, E; Mittal, S; Nickenig, G; Rinaldi, A; Rudzinski, P; Russo, M; Starck, C; von Bardeleben, RS; Wunderlich, N; Zamorano, JL; Hahn, RT; Maisano, F; Leclercq, C.
Tricuspid valve disease and cardiac implantable electronic devices
EUR HEART J. 2024; 45(5): 346-365. Doi: 10.1093/eurheartj/ehad783 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Andreas Martin
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers. Graphical Abstract Definition of TR in the presence of a CIED lead. CIED, cardiac implantable electronic device; TR, tricuspid regurgitation.
Find related publications in this database (Keywords): Pacemaker; Cardiac implantable electronic device; Tricuspid regurgitation; Lead related